Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/1990
08/29/1990EP0383919A1 Staurosporin derivatives
08/29/1990CN1044934A Tris-hydroxymethyl lower alkane as fat mimetics
08/28/1990US4952694 Novel resolution process for racemic spiro-hydantoins
08/28/1990US4952692 Calcium channel blockers; cardiovascular agents
08/28/1990US4952602 Treatment of arteriosclerosis
08/28/1990US4952598 3-phenyl indolinone derivatives, processes for their preparation, medicaments containing them, and their use
08/28/1990US4952568 Remedies and preventives for diabetic diseases
08/28/1990US4952567 Administering a protein kinase antagonist
08/24/1990WO1990009992A1 Novel vitamin d analogues
08/24/1990WO1990009991A1 Novel vitamin d analogues
08/23/1990WO1990009193A1 Increased protein production in animals
08/23/1990WO1990009176A1 Composition for reparation and prevention of fibrotic lesions
08/23/1990WO1990009173A1 Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
08/23/1990WO1990009163A2 Method and compounds for aica riboside delivery and for lowering blood glucose
08/22/1990EP0383607A1 Tris-hydroxymethyl lower alkane esters as fat mimetics
08/22/1990EP0383591A2 Use of 5-methyl-1-phenyl-2-(1H)-pyridone in the prevention and treatment of fibrotic lesions
08/22/1990EP0383472A2 Insulin analogs
08/22/1990EP0383453A1 A reg protein
08/22/1990EP0383432A1 Coenzyme Q10 with HMG-COA reductase inhibitors
08/22/1990EP0383129A2 Pancreatic islet cell antigens obtained by molecular cloning
08/22/1990EP0382935A1 2-(1H-imidazol-4(5)-yl)-3,4-dihydro-2H-1-benzothiopyran
08/22/1990EP0382772A1 Reduction of low density lipoproteins in biological fluids.
08/22/1990CN1044820A Insulin analogs
08/22/1990CN1044813A Calcium antagonists
08/22/1990CN1009278B Acid polycyclic ether antibiotic with the function of anticoccidiosis and growth promotion
08/21/1990US4950669 Side effect reduction
08/21/1990CA2010334A1 Dihydroxynaphthalene derivatives
08/18/1990CA2010220A1 2,4-dihalogeno-6-pyridylethanolphenylisopropylamines, processes for their preparation and their use for shifting the protein-fat ratio in favour of protein
08/16/1990EP0382618A2 Aminoalkoxyphenyl derivatives, process for their preparation and compositions containing them
08/16/1990EP0382199A1 Oxazole compounds and their use
08/16/1990EP0381823A2 Cytotropic heterogenous molecular lipids (CHML) and process for preparing the same
08/16/1990CA2005751A1 Tris-hydroxymethyl lower alkane esters as fat mimetics
08/15/1990CN1044656A Pyrazolopyridine compound and processes for preparation thereof
08/15/1990CN1044653A Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1-mediated conditions
08/15/1990CN1044591A Water dispersible gemfibrozil compositions
08/15/1990CN1044590A Method for preparing extended release gemfibrozil composition
08/14/1990US4948594 Readily absorbable by domestic livestock
08/14/1990CA1272717A1 Naphthothiazepinones
08/09/1990CA2045124A1 Increased protein production in animals
08/09/1990CA2008330A1 Calcium therapy treatment for milk fever
08/08/1990EP0381340A2 Peptides with sulphate ester groups
08/08/1990EP0381296A1 Kit for use in the treatment of osteoporosis
08/08/1990EP0381220A2 Water dispersible gemfibrozil compositions
08/08/1990EP0381219A2 Modified release gemfibrozil composition
08/08/1990EP0381218A2 Extended release gemfibrozil composition
08/08/1990EP0381142A2 Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
08/08/1990EP0381141A2 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions
08/08/1990EP0381075A2 Method for treating addiction to a drug of abuse employing an ace inhibitor
08/08/1990EP0381074A2 Method for facilitating dieting employing an ACE inhibitor
08/08/1990EP0380501A1 Glycosaminoglycan for the treatment of diabetic microangiopathy.
08/08/1990CN1044465A 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
08/08/1990CA2009470A1 Oxazole compounds and their use
08/07/1990WO1990008761A1 Phenylsulphone derivatives
08/07/1990US4946987 N-naphthoylglycine derivatives
08/07/1990US4946963 Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones
08/07/1990US4946866 Reduction of cholesterol or triglyceride concentration; treatment of arteriosclerosis and cardiovascular disorders
08/07/1990US4946864 Novel HMG-CoA reductase inhibitors
08/07/1990US4946861 1,3-dithian-2-ylidenes, their oxides, pharmaceutical compositions, and methods of use thereof
08/07/1990US4946852 Anticholesterol agent
08/07/1990US4946841 Pyridazine 3,5-dihydroxy carboxylic acids and derivatives thereof, the use thereof for hypercholesterolemia
08/07/1990US4946840 Benzazepine and benzothiazepine derivatives
08/07/1990US4946834 Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
08/07/1990US4946675 Hepatic blocking agents
08/07/1990US4946437 Method for the stimulation of bone marrow cells
08/07/1990CA2026003A1 Phenylsulphone derivatives
08/06/1990CA2008985A1 Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
08/04/1990WO1990008763A1 Arylsulphonyl-nitromethanes, process for their preparation and pharmaceutical compositions
08/04/1990WO1990008762A1 Heterocyclic sulphonylnitrometanes, process for their preparation and pharmaceutical compositions
08/04/1990CA2025768A1 Arylsulphonyl-nitromethanes, process for their preparation and pharmaceutical compositions
08/04/1990CA2025664A1 Heterocyclic sulphonylnitrometanes, process for their preparation and pharmaceutical compositions
08/02/1990DE4002836A1 Arzneistoffkombination aus einem hmg coa-reduktase-inhibitor und einem squalen-synthetase-inhibitor zur verwendung bei der senkung des serum-cholesterinspiegels und/oder zur vorbeugung oder behandlung von arteriosklerose Drug combination of a HMG CoA reductase inhibitor and a squalene synthetase inhibitor, for use in lowering serum cholesterol levels and / or for the prevention or treatment of arteriosclerosis
08/02/1990DE4002825A1 Arzneistoffkombination aus einem squalen-synthetase-inhibitor und einem anderen, das serum-cholesterin absenkenden wirkstoff Drug combination of a squalene synthetase inhibitor and another, the serum cholesterol-lowering drug
08/02/1990CA2009136A1 Water dispersible gemfibrozil compositions
08/02/1990CA2009135A1 Modified release gemfibrozil composition
08/02/1990CA2009134A1 Extended release gemfibrozil composition
08/01/1990EP0380392A2 Derivatives of benzocycloalkenyl dihydroxyalkanoic acids, methods of making them and phrmaceuticals containing them
08/01/1990EP0380331A1 (Di-tert-butylhydroxyphenyl)-thio derivatives, their preparation and use
08/01/1990EP0379979A1 Pyrazolopyridine compounds and processes for preparation thereof
08/01/1990EP0379936A2 Pyridoxal for use in enzyme deficiencies, and a diagnostic kit for their diagnosis
08/01/1990EP0379928A2 Aryl- and heteroarylethanol-pyridylalkylamines, process for their preparation and their use as performance stimulators by animals and as anti-adipositas agent
08/01/1990EP0379483A1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES AND 10-AZA, 10-OXA AND 10-THIA ANALOGUES
08/01/1990CA2007643A1 Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination
08/01/1990CA2007641A1 Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
07/1990
07/31/1990US4945158 Antidiabetic phosphonates
07/31/1990US4944944 For increasing fat absorption and animal growth; infant formulas
07/30/1990CA2007525A1 Method for facilating dieting employing an ace inhibitor
07/30/1990CA2007524A1 Method for treating addiction to a drug of abuse employing an ace inhibitor
07/27/1990WO1990008773A1 Peptides with sulphate ester groups
07/27/1990CA2026005A1 Peptides with sulphate ester groups
07/26/1990WO1990008775A1 POLYPEPTIDES HAVING A HUMAN β ADRENERGIC RECEPTOR ACTIVITY, AND PLAYING A ROLE IN LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF SAID POLYPEPTIDES FOR SCREENING SUBSTANCES WHICH ACT ON THESE POLYPEPTIDES
07/26/1990WO1990007926A1 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
07/26/1990WO1990007861A1 CHIMERIC IMMUNOGLOBULINS SPECIFIC FOR p55 TAC PROTEIN OF THE IL-2 RECEPTOR
07/26/1990CA2008439A1 Aryl-and heteroarylethanol-pyridylalkylamines, process for the preparation thereof and the use thereof as production promoters in livestock and as agents against obesity
07/25/1990EP0379314A1 3-(1,2,5,6-Tetrahydropyridyl)-pyrrolopyridines
07/25/1990EP0379161A2 Use of alkylated polyethyleneimines as therapeutic agent adsorbing bile acid and pharmaceutical compositions thereof
07/25/1990EP0378850A2 Substituted pyrido(2,3-d) pyrimidines
07/25/1990EP0378671A1 Insulinomimetic and insulin receptor binding site peptides.
07/25/1990CN1044105A Compounds
07/24/1990US4943641 Reacting protected 3-sulfonyloxyazetidine with alkali metal phthalimide, then hydrazine and catalytic hydrogenation
07/24/1990US4943630 Method for carrying out the organic synthesis of oligosaccharides containing galactosamine-uronic acid patterns, new oligosaccharides obtained and biological applications thereof
1 ... 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 ... 1298